Germline BRCA mutation evaluation in a prospective triple-negative breast cancer registry: implications for hereditary breast and/or ovarian cancer syndrome testing

NCCN guidelines recommend genetic testing for all triple-negative breast cancer (TNBC) patients aged ≤60 years. However, due to the lack of prospective information in unselected patients, these guidelines are not uniformly adopted by clinicians and insurance carriers. The aim of this study was to de...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Sharma, Priyanka, Klemp, Jennifer R., Kimler, Bruce F., Mahnken, Jonathan D., Geier, Larry J., Khan, Qamar J., Elia, Manana, Connor, Carol S., McGinness, Marilee K., Mammen, Joshua M. W., Wagner, Jamie L., Ward, Claire, Ranallo, Lori, Knight, Catherine J., Stecklein, Shane R., Jensen, Roy A., Fabian, Carol J., Godwin, Andrew K.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2014
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4171847/
https://ncbi.nlm.nih.gov/pubmed/24807107
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-014-2980-0
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi